TET 830 modified/T-helper epitope from tetanus toxoid

• CAT Number: I044272
• CAS Number: 410527-75-2
• Molecular Formula: C83H134N20O24
• Molecular Weight: 1796.07
• Purity: ≥95%
• IUPAC Name: (2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid
• InChI: InChI=1S/C83H134N20O24/c1-12-43(6)65(79(122)89-40-63(109)100-66(44(7)13-2)81(124)103-68(48(11)105)82(125)94-55(31-33-64(110)111)74(117)98-59(83(126)127)36-42(4)5)101-76(119)56(37-49-22-16-15-17-23-49)96-72(115)53(25-19-21-35-85)92-78(121)60(41-104)99-75(118)58(39-62(88)108)95-70(113)47(10)90-71(114)52(24-18-20-34-84)93-80(123)67(45(8)14-3)102-77(120)57(38-50-26-28-51(106)29-27-50)97-73(116)54(30-32-61(87)107)91-69(112)46(9)86/h15-17,22-23,26-29,42-48,52-60,65-68,104-106H,12-14,18-21,24-25,30-41,84-86H2,1-11H3,(H2,87,107)(H2,88,108)(H,89,122)(H,90,114)(H,91,112)(H,92,121)(H,93,123)(H,94,125)(H,95,113)(H,96,115)(H,97,116)(H,98,117)(H,99,118)(H,100,109)(H,101,119)(H,102,120)(H,103,124)(H,110,111)(H,126,127)/t43-,44-,45-,46-,47-,48+,52-,53-,54-,55-,56-,57-,58-,59-,60-,65-,66-,67-,68-/m0/s1
• InChIKey: DSPWLXQUCZCXNE-WQEOOASFSA-N
• SMILES: CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N

TET 830 Modified（Cat No.:I044272）, a T-helper epitope derived from tetanus toxoid, is a synthetic peptide commonly used to enhance immune responses in vaccine development and immunological studies. This modified version of the TET 830 epitope retains its MHC class II binding properties, allowing it to effectively stimulate CD4+ T cells. It is often conjugated to weakly immunogenic antigens to boost their immunogenicity through T-cell help. Widely used as a universal helper epitope, TET 830 modified supports the design of peptide-based vaccines and immunotherapies by promoting robust and targeted immune activation.